Sowell Financial Services LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$65.78 - $105.02 $80,317 - $128,229	-1,221 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$64.07 - $91.75 $12,621 - $18,074	-197 Reduced 13.89%	1,221 $86,000
Q4 2020 Jan 13, 2021	BUY	$65.07 - $98.24 $7,808 - $11,788	120 Added 9.24%	1,418 $122,000
Q3 2020 Nov 12, 2020	SELL	$59.04 - $77.95 $51,837 - $68,440	-878 Reduced 40.35%	1,298 $84,000
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $36,262 - $92,787	1,250 Added 134.99%	2,176 $159,000
Q1 2020 May 12, 2020	SELL	$27.51 - $57.29 $9,876 - $20,567	-359 Reduced 27.94%	926 $32,000
Q4 2019 Feb 07, 2020	BUY	$40.86 - $57.65 $42,698 - $60,244	1,045 Added 435.42%	1,285 $69,000
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $8,971 - $11,872	240 New	240 $10,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.